Greg Hodge was awarded the Lung Foundation Australia/Boehringer Ingelheim Fellowship 2012 and talks about the research he was able to conduct thanks to this award which looks at reducing steroid resistance by targeting P-gp1 on pro-inflammatory T-cell subsets to reduce inflammation in Chronic Obstructive Pulmonary Disease (COPD).
For further information contact our Information and Support Centre on 1800 654 301.